Corrigendum: Synergistic effects of nab-PTX and anti-PD-1 antibody combination against lung cancer by regulating Pi3K/AKT pathway through the Serpinc1 gene

Affiliations

Jun Zhang: Department of Clinical Pharmacy, School of Pharmacy, Fudan University, Shanghai, China
Zhijia Tang: Department of Clinical Pharmacy, School of Pharmacy, Fudan University, Shanghai, China
Xi Guo: Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
Yunxia Wang: Department of Clinical Pharmacy, School of Pharmacy, Fudan University, Shanghai, China
Yuhong Zhou: Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
Weimin Cai: Department of Clinical Pharmacy, School of Pharmacy, Fudan University, Shanghai, China

Abstract

No abstracts available.

ISSN: 2234-943X (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.frontiersin.org/journals/oncology/